Search results
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 2 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 4 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 2 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID summer wave grows, with new variant LB.1 on the rise
WLTX-TV Columbia· 4 hours agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 12 hours agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 7 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 4 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...